Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
about
Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.Development of daptomycin for gram-positive infections.Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Resistance studies with daptomycinDaptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects.Daptomycin.In vitro activities of a new lipopeptide, HMR 1043, against susceptible and resistant gram-positive isolatesLipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections.Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilmDaptomycin nonsusceptible enterococci: an emerging challenge for clinicians.Physical and chemical compatibility of daptomycin with nine medications.Successful treatment of Corynebacterium striatum endocarditis with daptomycin plus rifampin.Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.Daptomycin: a novel agent for Gram-positive infections.
P2860
Q33218606-D59AB805-FD2F-4BF6-8D5E-3C018378A486Q33920377-DC6B7BC8-54B5-49A8-8092-74E3C73F0F39Q33981666-0CD5C52D-4ED9-4671-AC9E-A3F3AB6D7046Q33982318-CFD6A102-DC8F-4CDD-9FD4-6F1E30B3D605Q34882125-87C68290-559F-46B5-8AF6-190B196066A9Q35637066-93BAD2FD-140E-433F-A48E-5B989E0497ECQ35685332-FA15D83D-9893-4C68-BC2C-0470DBF0E27CQ35871928-5B663673-8983-4204-86AC-5899C7B9F51BQ35933388-5497D179-8829-47A7-8A24-205256AB6FC1Q36757565-F95BF1FF-3EFA-40AB-A86D-AC791BA804FBQ44579110-86650C1F-4A43-4952-9088-4CBFF5B03A1AQ45029806-8E231A7C-2107-43C9-B76F-83E374F482FDQ46689355-9BFDCDE5-FF82-49FC-9712-9D68BA77B7B7Q46908684-D2C095AC-5BA4-4DFB-8127-538D96F4A5E4Q53852746-41AA877F-3B53-4A7F-BC9F-C5E325CC76EE
P2860
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@en
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@nl
type
label
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@en
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@nl
prefLabel
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@en
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@nl
P2093
P356
P1433
P1476
Comparison of in vitro inhibit ...... tamicin-resistant enterococci.
@en
P2093
P304
P356
10.1159/000239141
P577
1993-09-01T00:00:00Z